2,120
Participants
Start Date
June 30, 2010
Primary Completion Date
May 31, 2011
Nepafenac Ophthalmic Suspension, 0.3%
Nepafenac Ophthalmic Suspension, 0.3%, one drop in affected eye once daily, for 16 days. An additional dose was administered between 30-120 minutes prior to surgery.
Nepafenac Ophthalmic Suspension, 0.1%
Nepafenac Ophthalmic Suspension, 0.1%, one drop in affected eye three times daily, for 16 days
Nepafenac Ophthalmic Suspension 0.3% Vehicle
Nepafenac 0.3% vehicle, one drop in affected eye once daily, for 16 days. An additional dose was administered between 30-120 minutes prior to surgery.
NEVANAC Vehicle
Nepafenac vehicle, one drop in affected eye three times daily, for 16 days
Contact Alcon Call Center For Trial Locations, Fort Worth
Lead Sponsor
Alcon Research
INDUSTRY